|
|
Line 476: |
Line 476: |
|
| |
|
| ==Anaplastic thyroid carcinoma== | | ==Anaplastic thyroid carcinoma== |
| ===Epidemiology===
| | {{Main|Anaplastic thyroid carcinoma}} |
| *Very rare.
| |
| *Horrible prognosis.
| |
| *Often presents with obstruction.
| |
| *Typically there is a history of a thyroid mass.
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *Cytologically malignant:
| |
| **Huge [[NC ratio]].
| |
| **Mitoses.
| |
| *+/-[[Necrosis]].
| |
| | |
| Notes:
| |
| *May have features of other thyroid carcinomas, e.g. psammoma bodies, papillae, nuclear changes of PTC.
| |
| | |
| Image: [http://commons.wikimedia.org/wiki/File:Anaplastic_thyroid_carcinoma_low_mag.jpg Anaplastic thyroid carcinoma with a component of papillary thyroid carcinoma (WC)].
| |
| | |
| DDx:
| |
| *[[Poorly differentiated carcinoma of the thyroid|Poorly differentiated thyroid carcinoma]].
| |
| *[[Squamous cell carcinoma]].
| |
| *[[Medullary thyroid carcinoma]].
| |
| *Sarcoma.
| |
| | |
| ===IHC===
| |
| *Keratin (AE1/AE3) +ve.
| |
| *Vimentin +ve, >90%.<ref name=pmid1712540>{{cite journal |author=Ordóñez NG, El-Naggar AK, Hickey RC, Samaan NA |title=Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases |journal=Am. J. Clin. Pathol. |volume=96 |issue=1 |pages=15–24 |year=1991 |month=July |pmid=1712540 |doi= |url=}}</ref>
| |
| *Thyroglobulin - rarely +ve (~15%).<ref name=pmid1712540/>
| |
| *CEA -ve, calcitonin -ve; to r/o medullary.
| |
| *p53 +ve.
| |
| *[[TTF-1]] +ve.
| |
|
| |
|
| ==Lymphomas of the thyroid== | | ==Lymphomas of the thyroid== |